The ability to measure PSA concentrations at or below ng per liter may enable early detection of relapse for surgically treated prostate cancer patients (29,30) and it can potentially also assist diagnoses of hyperandrogenism in polycystic ovarian syndrome, which is a common cause of reproductive and metabolic dysfunction in women (31). This evidence concerns the gene KLK3 and polycystic ovary syndrome.